Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review

• Κύριοι συγγραφείς: Shiva Toumaj (Συγγραφέας), Shahrzad Alimohammadi (Συγγραφέας), Maryam Ghasemi (Συγγραφέας), Shokouh Shayanpour (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Society of Diabetic Nephropathy Prevention, 2023-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Immunoglobulin A nephropathy is the most common kind of primary glomerulonephritis worldwide and one of the main causes of renal failure. Systemic corticosteroid therapy may protect against renal deterioration in IgA nephropathy; however, it is not often advised for long-term treatment due to possib...